Structure-based drug discovery services for pharma and biotech
Proteros runs a structure-based drug discovery operation serving 250+ pharmaceutical and biotech clients globally, with particular depth among the largest pharma firms. The tech stack is heavily computational (SQL Server, Power BI, Azure Data Factory, Python, Perl) paired with specialized research instrumentation (X-ray crystallography, cryo-EM, biophysical assays), reflecting a hybrid services model that bridges wet-lab and data infrastructure. Active hiring is concentrated in research roles with senior-heavy seniority mix, while concurrent digitalization projects targeting legal workflows and process optimization suggest internal operations scaling is a near-term priority.
Proteros is a privately held services provider founded in 2000, headquartered in Planegg-Martinsried, Bavaria. The company operates a structure-based drug discovery platform combining protein crystallography, cryo-EM, biophysical screening, and assay development, supporting clients in the US, Europe, and Japan. With 51–200 employees and active operations across research, sales, data, and compliance functions, Proteros works with the top 20 global pharma companies and a broader partner base of mid-market biotech firms. The company is hiring in Germany across multiple seniority levels, with particular emphasis on research roles.
Proteros provides structure-based drug discovery services including protein X-ray crystallography, cryo-EM imaging, protein production, biophysical and biochemical assays, binding and functional assays, and screening solutions for challenging research targets.
Proteros runs Microsoft Office, SQL Server, Power BI, Power Query, Azure Data Factory, SQL Server Integration Services, and DAX for data infrastructure, plus Python, Perl, and Bash for computation, alongside specialized biophysics instruments like X-ray crystallography and cryo-EM systems.
Other companies in the same industry, closest in size